Ordonez Claudia

Track

Insider profile

Ordonez Claudia's trades of Keros Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
274.88
Quantity 19,046 +43.3%
Value US$4,511,565
Transaction date
Planned sale
Price
253.15
Quantity 37,562 +20.7%
Value US$3,426,237
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-06-15 2021-06-11
PlS Planned sale
19,046 +43.3%
274.88
US$4,511,565 		19,046 +43.3% 274.88 US$4,511,565
2021-06-15 2021-06-11
PlS Planned sale
37,562 +20.7%
253.15
US$3,426,237 		37,562 +20.7% 253.15 US$3,426,237
2021-05-13 2021-05-11
PlS Planned sale
60,345 +12.6%
235.59
US$195,771 		60,345 +12.6% 235.59 US$195,771
2021-04-14 2021-04-12
PlS Planned sale
233 -100.0%
61.23
US$14,267 		233 -100.0% 61.23 US$14,267
2021-04-14 2021-04-12
PlS Planned sale
367 -61.2%
60.01
US$22,024 		367 -61.2% 60.01 US$22,024
2021-04-14 2021-04-12
PlS Planned sale
400 -40.0%
59.09
US$23,636 		400 -40.0% 59.09 US$23,636
2021-03-15 2021-03-11
PlS Planned sale
605 -100.0%
64.86
US$39,240 		605 -100.0% 64.86 US$39,240
2021-03-15 2021-03-11
PlS Planned sale
395 -39.5%
64.09
US$25,316 		395 -39.5% 64.09 US$25,316
2021-02-16 2021-02-11
PlS Planned sale
2 -100.0%
68.05
US$136 		2 -100.0% 68.05 US$136
2021-02-16 2021-02-11
PlS Planned sale
295 -99.3%
66.19
US$19,526 		295 -99.3% 66.19 US$19,526
2021-02-16 2021-02-11
PlS Planned sale
216 -42.1%
65.35
US$14,116 		216 -42.1% 65.35 US$14,116
2021-02-16 2021-02-11
PlS Planned sale
312 -37.8%
64.17
US$20,021 		312 -37.8% 64.17 US$20,021
2021-02-16 2021-02-11
PlS Planned sale
175 -17.5%
63.10
US$11,042 		175 -17.5% 63.10 US$11,042